Reporter brief
Metabolic Optimization and Training InterVentions for Aging and Type 2 Diabetes to Enhance Cognition: the MOTIVATE Study
What happened
Trial registry update: NOT_YET_RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- This is a study protocol describing planned research, not results—no efficacy of exercise or semaglutide on cognition has been demonstrated yet.
- The unequal intervention durations (32 weeks exercise vs. 16 weeks semaglutide) mean any cognitive benefits cannot be attributed to semaglutide alone without accounting for the differential treatment periods.
- The abstract does not report which cognitive outcomes are primary, how many participants are being enrolled, or what the statistical power is to detect meaningful effects.
Study design and sample
Rct; Human.
Older adults with Type 2 diabetes
- Design
- Rct
- Sample
- —
- Journal
- Western University, Canada
- Published
- Aug 20, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Exercise timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.